Slash Your Wegovy Costs: Novo Nordisk Reveals First-Ever Subscription Plan – Novo Nordisk (NYSE:NVO)
Earlier in March, the U.S. Food and Drug Administration (FDA) approved a higher-dose version of Wegovy, marking an…
Hims & Hers, Novo Nordisk Weight-Loss Drug Deal Ends Legal Feud, Stock Soars – Hims & Hers Health (NYSE:HIMS)
Novo Nordisk Partners with Hims & Hers Novo Nordisk has decided to sell its weight-loss drug through Hims…
Novo Nordisk And Hims & Hers End Bitter Legal Feud With Surprise Weight-Loss Drug Deal: Report – Hims & Hers Health (NYSE:HIMS), Eli Lilly (NYSE:LLY)
Novo Nordisk AS (NYSE:NVO) and Hims & Hers Health Inc. (NYSE:HIMS) have reportedly ended their public feud, with…
Hims & Hers Health, Novo Nordisk, PayPal, Uber And BWX Technologies: Why These 5 Stocks Are On Investors’ Radars Today – Hims & Hers Health (NYSE:HIMS)
Major U.S. indices traded higher Monday, with Dow Jones Futures edging up 0.09% to 48,893, the S&P 500…
Novo Nordisk CEO Sees Opportunity For 15 Million New Patients As Medicare Covers Obesity Drugs – Hims & Hers Health (NYSE:HIMS), Eli Lilly and Co (NYSE:LLY)
Novo Nordisk (NYSE:NVO) CEO Mike Doustdar said the company aims to reach about 15 million new patients when…
Novo Nordisk Takes Legal Action Against Hims & Hers Over Wegovy Knock Offs – Hims & Hers Health (NYSE:HIMS), Novo Nordisk (NYSE:NVO)
Novo Nordisk A/S (NYSE:NVO) on Monday said it has filed a lawsuit against telehealth company Hims & Hers…
Gartner, Stellantis, And Novo Nordisk Are Among Top 10 Large Cap Losers Last Week (Feb. 2-Feb. 6): Are the Others in Your Portfolio? – Boston Scientific (NYSE:BSX), IQVIA Hldgs (NYSE:IQV), IREN (NASDAQ:IREN), Novo Nordisk (NYSE:NVO)
These ten large-cap stocks were the worst performers last week. Are they a part of your portfolio? Stellantis N.V.…
What’s Going On With Novo Nordisk Stock On Friday? – Novo Nordisk (NYSE:NVO)
Novo Nordisk A/S (NYSE:NVO) is trading higher on Friday after falling for two consecutive days on lower-than-expected fiscal…